Direction générale des études et des statistiques sectorielles - Ouagadougou
1
Dr. Ouangare A., Ouedraogo S., Da D. et al.
1
Drug Safety
1
Dzabala, N. et al.
1
E. André
1
ECPAT France et ECPAT Luxembourg
1
et al
1
et Ondoua Biwole V.
1
Eurosurveillance
1
F. Griffiths, and J. Goudge
1
F. M. Arenas, P. Loock
1
Fanning, A.
1
Fast SM, Mekaru S, Brownstein JS, Postlethwaite TA, Markuzon N.
1
Ferreyra C., D. O’Brien, B. Alonso
1
FIGO LOGIC
1
Frontiers in Pediatrics
1
Frontiers in Public Health
1
Gajda M., E. Urban
1
Garcia, P.J.
1
German Institute for Medical Mission
1
Global Task Force on Cholera
1
Grimshaw, J. M.
1
H. Getahun
1
H.Kanyerere, A.D. Harries, K. Tayler-Smith, et al.
1
HAL archives ouvertes
1
HEART
1
Hickel, J.
1
IACAPAP
1
ICAP
1
ICF International
1
Imperial College COVID-19 Response Team
1
Institut für Public Health und Pflegeforschung, Universität Bremen
1
Instituto Nacional de enfermedades respiratorias
1
Inter-Agency Standing Committee IASC
1
International Federation of Red Cross and Red Crescent Societies, Water and Sanitation Mission Assistant
1
International Initiative for Impact Evaluation (3ie)
1
International Union Against Tuberculosis and Lung Disease
1
J. Caldwell
1
J. LEGRAND, R. F. GRAIS, P. Y. BOELLE, A. J. VALLERON, and A. FLAHAULT
1
Jassat, W.
1
Journal of AIDS & Clinical Research
1
Journal of the International AIDS Society (JIAS)
1
Jusot, V.
1
K. Ciceri
1
K. Lancaster
1
Kaufmann, B.
1
Ker K, Tansley G, Beec her D, Perner A, Shakur H, Harris T, Roberts I
1
Kouyate B. A.
1
Labonté et al
1
Le Projet Sphère
1
Les pressen universitaires de Yaounde
1
Longo J. de Dieu
1
M. Higgins-Biddle
1
M. Joffres
1
M. Prescott, C. Boeke, T. Gotora, et al.
1
M. Schomaker
1
M. Snowling
1
M.-A. Davies
1
Malaria Journal
1
Mark F. Cotton
1
Masekela, R.
1
Mburu, Gitau
1
Medecins Sans Frontieres
1
Medecins Sans Frontiers
1
Médecins du Monde
1
Médecins Sans Frontière
1
Médecins sans Frontières MSF
1
Ministerio de Salud Publica, Santo Domingo
1
Ministère de la santé - Burkina Faso
1
Ministère de la santé - Secrétariat Général - Direction Général de l'information et des statistiques sanitaires
1
Ministère de la Santé à travers la Direction de la Santé de la Famille
1
Ministère de la Santé de Madagascar
1
Ministère de la Santé Publilque, Repubique Democratique du Congo,
1
Ministère de la Santé Publique et de la Population (MSPP) Haiti
1
Ministère de la Santé Publique et de la Population (MSPP) Haiti, the Centers for Disease Control, and the World Bank.
1
Ministère de la Santé Publique, République Démocratique du Congo
1
Ministère de la Santé, Direction de la Santé de la Mère et de l’Enfant, République du Bénin
1
Ministère de la Santé, République du Bénin
1
Ministère du Plan et de l’Economie Institut Centrafricain des Statistiques et des Etudes Economiques et Sociales
1
Ministry of Health & Family Welfare, India
1
Minstère de la santé - Secrétariat général - Direction général de la pharamcie du médicament et des laboratoires
1
Mortimer, K.
1
Moungou Mbenda S.
1
MSF South Africa and Lesotho
1
Mukhtar A Adeiza, Abdullah A Abba, Juliana U Okpapi
1
National Department of Health (NDoH) South Africa
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Niada T. F., M. Kircher, S. Kangnama et. al.
1
Nwe Ni Myint et al.
1
O'Neill, D.
1
OMS
1
ONUSIDA
1
Oranizatión Panamerica de la Salud
1
Organisation de la Santé Mondiale
1
Organisation Mondiale de la Santé
1
Organización Mundial de la Salud Américas
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
1
Ozoh, O.
1
P. J. Dodd
1
P. Mulongeni
1
P. Puch-Serres, Kuster M., Mathavan G., et al.
1
PLOS Medicine
1
Portaels, F.
1
PubMed.gov
1
R Wood, L-G. Bekker
1
R. Muloiwa
1
Reusken C. B. E. M., E. K. Broberg, B. Haagmans et al.
1
République Démocratique du Congo, Ministère de la Santé Publique, Programme National de la Lutte contre le Paludisme (PNLP)
1
République du Cameroon
1
Rhodes, T.
1
S. A. Madhi
1
S. H.-L. Fry
1
S. Hermans
1
S. K. Dlamini
1
S. L. Barnabas
1
S. Lees et al.
1
S. Nag
1
Saranya A, Selvaraj E Lee, Mason Harrell, et al.
1
Science Publishing Group
1
Shears, Paul, T.J.D. O'Dempsey
1
Slama, S.
1
Southern African Journal of HIV Medicine
1
Takarinda, Kudakwashe C., Lydia K. Madyira, Mutsa Mhangara, Victor Makaza, Memory Maphosa, Simbarashe Rusakaniko, Peter H. Kilmarx, Tsitsi Mutasa-Apollo, Getrude Ncube, and Anthony D. Harries
1
Tchibozo,H.B.M.
1
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
1
The Lancet
1
Thomas, L.S., E. Buch and Y. Pillay
1
U.S. Global Malaria Coordinator
1
Unité-Progrès-Justice - Institut national de la statistique et de la démographie - Burkina Faso
1
USAID, et al.
1
Van Katwyk, S. R.
1
WaterAid
1
Watkins, J:W.
1
WHO
1
WHO, THE END TB STRATEGY
1
World Bank.
1
World Health Organization (WHO)
1
World Health Organization WHO, Regional Office of Europe
1
World Health Organization, TB HIV working group, Stop TB Partnership
In resource-limited countries, the number of available antiretroviral (ARV) drugs is relatively limited. Hence, caregivers face some caution and constraints in the changes of ARV treatment (ART) in people living with HIV (PLHIV). Our objective was to calculate the incidence, to describe the main cau...ses and to identify the predictive factors of the first change of ARV treatment in Senegal.more
Community health workers (CHWs) enable marginalised communities, often experiencing structural poverty, to access healthcare. Trust, important in all patient–provider relationships, is difficult to build in such
communities, particularly when stigma associated with HIV/AIDS, tuberculosis and now ...COVID-19, is widespread.
CHWs, responsible for bringing people back into care, must repair trust. In South Africa, where a national CHW programme is being rolled out, marginalised communities have high levels of unemployment, domestic violence and injury. In this complex social environment, we explored CHW workplace trust, interpersonal trust between the patient and CHW, and the institutional trust patients place in the health systemmore
Objective: The study aimed to describe the current epidemiological, clinical and immunological profile of newly
detected HIV - positive patients in Northern Benin by 2016. Methods: It was a prospective study conducted from May 2 to
October 31, 2016 on three main sites of care of people living with... HIV (PLHIV) in the department of Borgou in Benin. All
new cases of HIV infection have been systematically and comprehensively recruited. Initial epidemiological, clinical and
immunological data were collected using a questionnaire. These data were entered and analyzed using the Epi Info 7 software.
Results: In total, 185 adults (68 male and 117 female) newly screened HIV positive were included in this study. The middle age
was 36.2 ± 10.9 years and the sex ratio was 0.6 One hundred and thirty-five patients (73%) were between 25 and 50 years old.
In terms of the profession, 132 patients (71.3%) were engaged in liberal activities (craftmen, traders and retailers). The
majority was schooled (113 or 61.1%) and resided in urban areas (146 or 79%). One hundred and sixteen patients lived in
couple (62.7%) with an average monthly income estimated at 70 US Dollars. Clinically, 123 patients (66.5%) were in WHO
stage III. The body mass index was over 18.5 kg/m2 in 124 patients (67%). The median number of TCD4 lymphocytes was
254.5 cells/ml and 25 patients (13.5%) had a number of CD4 over 500 cells/ml. HIV1 was really predominant (97.8%). Most
patients (152 or 82.2%) had been screened for clinical suspicion. Conclusion: HIV infection in Benin remains the prerogative
of young, female, educated and poor people. Screening is delayed and hence the need to develop innovative strategies for earlymore
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care... for high-risk patients give few or no recommendations about how, by whom, or where they should be delivered for optimal impact. more
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...that was developed to expand HIV care capacity in Yangon, Myanmar. The partnership was between private sector general practitioners (GPs) and a community‐based non‐governmental organization (International HIV/AIDS Alliance).
https://doi.org/10.7448/IAS.19.1.20926more
To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.
This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was ba...sed on clinical data recorded using ESOPE software and analysed using Excel and SAS.more
Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...Es) by strengthening passive safety
surveillance via PV training and mentoring of local PV stakeholders and healthcare providers (HCPs) at their own healthcare
facilities (HCFs).
Methods An 18-month PV training and mentoring programme was implemented in collaboration with national stakeholders,
and in partnership with the Ministry of Health, GSK and PATH. Two-day training was provided to Expanded Programme on
Immunisation coordinators, identified as responsible for AE reporting, and four National Regulatory Authority representa-
tives. Abridged PV training and mentoring were provided regularly to HCPs. Support was given in upgrading the national
PV system. Key performance indicators included the number of AEs reported, transmission of AE forms, completeness of
reports, serious AEs reported and timeliness of recording into VigiFlow.
Results In 18 months, 443 HCPs at 61 HCFs were trained. The number of reported AEs increased from 22 (January 2000 to
October 2016) to 228 (November 2016 to May 2018), enabling Malawi to become a member of the World Health Organization
Programme for International Drug Monitoring. Most (98%) AE report forms contained mandatory information on reporter,
event, patient and product, but under 1% were transmitted to the national PV office within 48 h.
Conclusion Regular PV training and mentoring of HCPs were effective in enhancing passive safety surveillance in Malawi,
but the transmission of reports to the national PV centre requires further improvement.more